Pharma and Biotech
By Josh White
Date: Friday 12 Apr 2024
(Sharecast News) - Oxford Nanopore took the wraps off a "groundbreaking" study using its technology on Friday, shedding light on the measurement of human telomeres - the protective caps at the ends of chromosomes crucial for genome integrity.
By Josh White
Date: Wednesday 06 Mar 2024
(Sharecast News) - Molecular sensing technology developer Oxford Nanopore Technologies reported a fall in total revenue in its preliminary results for 2023 on Wednesday, despite a surge in life science research tool revenue, as it pushed out its forecast for reaching breakeven.
By Benjamin Chiou
Date: Monday 22 Jan 2024
(Sharecast News) - Oxford Nanopore Technologies has appointed Nick Keher, a finance veteran in the life sciences sector, as its new chief financial officer, the DNA/RNA sequencing tech firm announced on Monday.
Currency | UK Pounds |
Share Price | 98.35p |
Change Today | -5.85p |
% Change | -5.61 % |
52 Week High | 275.00 |
52 Week Low | 92.75 |
Volume | 16,576,370 |
Shares Issued | 859.96m |
Market Cap | £845.77m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:44 | 14,968,266 @ 97.00p |
17:09 | 70,000 @ 99.75p |
17:03 | 8,700 @ 98.35p |
16:48 | 666 @ 98.35p |
16:47 | 30,000 @ 99.58p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research